The news is full of stories about monumental surprise hospital bills, sky-high drug prices and patients going bankrupt. The government's approach to addressing this, via an executive order that President Trump signed June ...
Jun 25, 2019
0
0
Pupils from the poorest backgrounds are the ones most likely to leave school at lunchtime to buy food, a University of Hertfordshire investigation revealed today—and the choice is often chips together with other items high ...
May 10, 2019
0
0
An examination of U.S. hospital prices covering 25 states shows that in 2017, the prices paid to hospitals for privately insured patients averaged 241% of what Medicare would have paid, with wide variation in prices among ...
May 9, 2019
0
2
When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51.
Mar 14, 2019
1
9
Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency's response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage ...
Mar 5, 2019
0
0
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research.
Feb 4, 2019
0
15
House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political ...
Jan 14, 2019
0
0
The average price of cannabis in Canada went up 17.4 percent after its legalization, according to data released by the government statistical agency.
Jan 10, 2019
0
1
A few easily learned tips on eating and food choice can increase amount of healthy food choices between 5 percent and 11 percent, a new Yale University study has found.
Nov 13, 2018
0
42
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.
Oct 31, 2017
1
0
